H R Lijnen|D Collen - JoVE Visualize

Showing results (91-100 of 610) with videos related to

Pageof 61

Sort By:

Analytical Biochemistry|June 1, 1997

Screening panels of monoclonal antibodies using phage-displayed antigenH R Lijnen, I Lasters, M Verstreken, et al.

Blood|March 26, 1999

Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleedingH R Lijnen, K Okada, O Matsuo, et al.

Journal of Thrombosis and Haemostasis : JTH|June 29, 2007

Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in miceY Suzuki, N Nagai, K Umemura, et al.

Thrombosis and Haemostasis|December 1, 1996

Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activatorK Okada, H R Lijnen, H Moreau, et al.

Thrombosis and Haemostasis|July 10, 1998

Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin systemH R Lijnen, J Silence, G Lemmens, et al.

Thrombosis and Haemostasis|February 28, 1984

Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activationH R Lijnen, J Soria, C Soria, et al.

European Journal of Biochemistry|November 15, 1988

Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160H R Lijnen, L Nelles, B Van Hoef, et al.

Biochemistry|January 13, 2000

Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from a novel Chryseobacterium SpH R Lijnen, B Van Hoef, F Ugwu, et al.

Circulation|March 1, 1986

Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarctionD Collen, H Bounameaux, F De Cock, et al.

The Journal of Biological Chemistry|December 15, 1988

Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activatorH R Lijnen, L Nelles, B Van Hoef, et al.

Pageof 61

Showing results (91-100 of 610) with videos related to

Sort By:

Pageof 61

Analytical Biochemistry|June 1, 1997

Screening panels of monoclonal antibodies using phage-displayed antigenH R Lijnen, I Lasters, M Verstreken, et al.

Blood|March 26, 1999

Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleedingH R Lijnen, K Okada, O Matsuo, et al.

Journal of Thrombosis and Haemostasis : JTH|June 29, 2007

Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in miceY Suzuki, N Nagai, K Umemura, et al.

Thrombosis and Haemostasis|December 1, 1996

Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activatorK Okada, H R Lijnen, H Moreau, et al.

Thrombosis and Haemostasis|July 10, 1998

Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin systemH R Lijnen, J Silence, G Lemmens, et al.

Thrombosis and Haemostasis|February 28, 1984

Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activationH R Lijnen, J Soria, C Soria, et al.

European Journal of Biochemistry|November 15, 1988

Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160H R Lijnen, L Nelles, B Van Hoef, et al.

Biochemistry|January 13, 2000

Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from a novel Chryseobacterium SpH R Lijnen, B Van Hoef, F Ugwu, et al.

Circulation|March 1, 1986

Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarctionD Collen, H Bounameaux, F De Cock, et al.

The Journal of Biological Chemistry|December 15, 1988

Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activatorH R Lijnen, L Nelles, B Van Hoef, et al.

Pageof 61